Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential

Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease, is a clinically heterogeneous disorder, with obscure etiology and no disease-modifying therapy to date. Currently, there is no available biomarker for PD endophenotypes or disease progression. Accu...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, Christina Piperi
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2020-10-01
Цуврал:	Brain Sciences
Нөхцлүүд:	PD Arylsulfatase A lysosomes GWAS Gaucher’s disease prognostic biomarker
Онлайн хандалт:	https://www.mdpi.com/2076-3425/10/10/713
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!